The same genetic markers that flag celiac disease risk in European patients appear with equal force in Mauritanians — a West African population largely absent from celiac research. A study published today in BMC Gastroenterology found that two specific gene variants long associated with celiac risk in Europeans significantly elevate that same risk in a Mauritanian cohort. When the two variants are inherited together — a combination called a haplotype — the risk climbs even higher.
The finding stretches well beyond Mauritania’s borders. For decades, celiac disease has been studied primarily in Northern and Western European populations. That concentration has shaped which groups get screened, which families eventually receive a diagnosis, and which communities remain largely invisible to the medical system when it comes to celiac disease.
What This Means for You
If your family is in the United States or Europe, the direct clinical impact of this study may not be immediately obvious. These gene variants are not new discoveries — researchers have tracked them in European celiac patients for years. What is new is confirming they behave the same way in a West African population with distinct ancestry.
Celiac disease affects an estimated 1% of the global population, but diagnosis rates vary wildly by region. In populations that have received less research attention — across Africa, the Middle East, South Asia — celiac disease is almost certainly underdiagnosed. Not because it is rarer, but because the frameworks built to catch it were designed around European ancestry.
This study adds to a growing body of evidence that celiac disease’s genetic underpinnings are not ethnically specific. The uncomfortable implication is that millions of people worldwide are living with intestinal damage from undetected celiac disease — not because the condition spares them, but because the research was never built around them.
For celiac families in the United States with diverse ancestry — and for advocacy organizations working to expand awareness — that matters. The science is increasingly confirming what many patients and caregivers have argued for years: celiac disease is a universal human condition, not a niche diagnosis concentrated in one corner of the world.
I think about this as a parent. My son has celiac disease, and one of the clearest lessons I have taken from raising a child with this condition is how much depends on awareness at every level — from the pediatrician who takes the initial symptoms seriously to the school that understands cross-contact risk. None of that infrastructure exists without the underlying research establishing celiac as a condition worth screening for. Every study that broadens the evidence base brings that awareness one step closer to reaching families who are still waiting.
Key Takeaways
- The same gene variants (HLA-DQB1*02 and HLA-DRB1*03) that predict celiac risk in Europeans also significantly raise risk in Mauritanians.
- When these variants are inherited together as a haplotype, the risk is compounded beyond either variant alone.
- Celiac disease is not a condition of European ancestry. This study extends a growing body of evidence that it is global.
- Understudied populations worldwide likely carry substantial rates of undiagnosed celiac disease.
- Expanding genetic research to include African and other underrepresented groups is essential for accurate global prevalence estimates — and ultimately for better care.
The Science
Want to understand how this actually works? We’ll walk you through the technical details below and define every term. No medical degree required.
HLA Genes: The Immune System’s Identity Tags
To understand this research, start with HLA — Human Leukocyte Antigens. These are proteins found on the surface of nearly every cell in the body. Their job is to present fragments of proteins (called peptides — short chains of amino acids) to immune cells, helping the immune system identify foreign threats.
In celiac disease, this process misfires. When a person carries certain HLA variants, their immune system treats gluten peptides as dangerous invaders and launches an attack — one that damages the lining of the small intestine over time.
The most important risk variants are HLA-DQ2 and HLA-DQ8, the two proteins most strongly associated with celiac disease. Together, they account for the vast majority of celiac cases — roughly 90–95% of patients carry one or both.
Breaking Down the Specific Variants
HLA-DQB1*02 is the gene encoding the beta chain of the HLA-DQ2 protein — essentially one half of the molecular structure that causes the immune system to overreact to gluten. When this variant is present, the immune system is more prone to misidentifying gluten fragments and mounting a damaging response.
HLA-DRB1*03 is a closely related gene variant. It does not drive celiac disease independently, but it commonly travels alongside HLA-DQB1*02 on the same chromosome. When the two are inherited together, they form what geneticists call a haplotype — a cluster of gene variants passed down as a single unit from parent to child.
This HLA-DQB1*02–HLA-DRB1*03 haplotype is the genetic signature of the DR3-DQ2 combination that researchers have long linked to elevated celiac risk. Finding it in a Mauritanian population — with the same pattern of significantly increased risk — confirms that this mechanism operates identically across very different ancestral backgrounds.
Why Population Diversity in Research Matters
Most celiac genetic research has been conducted in European cohorts — Italians, Irish, Finns, Swedes. That is partly a legacy of where celiac disease was first described and intensively studied, and partly a reflection of where research infrastructure has historically been concentrated.
The problem with that concentration is self-reinforcing: populations not studied do not appear in clinical guidelines, so physicians in those regions have less incentive to screen, so celiac goes undetected, which reinforces the false assumption that the disease is rare there. And so the gap persists.
A Mauritanian cohort is a significant addition to this literature. Mauritania sits at the intersection of Sub-Saharan African and North African populations, with complex ancestral diversity. Documenting celiac-associated HLA variants there is a step toward building a complete and accurate picture of global celiac prevalence.
Researchers are also expanding the genetic picture in another direction — examining HLA variants beyond the well-studied DQ2 and DQ8. Earlier work on the functional overlap between HLA-DQ5 and DQ9 in gluten presentation explores how less common HLA types may also contribute to celiac susceptibility. Together, these lines of inquiry are steadily filling in the genetic map of who is at risk and why.
The Haplotype Effect: Risk Beyond Individual Variants
One of the more specific conclusions from this Mauritanian study is that the haplotype — HLA-DQB1*02 and HLA-DRB1*03 inherited together — confers greater risk than either variant alone. This aligns with what researchers have observed in European populations: when these variants appear on the same chromosomal segment, they amplify the probability that the immune system will misfire in response to gluten.
For genetic counseling, this distinction is clinically meaningful. A child who inherits both variants faces higher risk than a child who carries only one. Knowing which haplotype is present can help physicians stratify risk and make more targeted decisions about when to recommend screening — and this study suggests those decisions should apply equally regardless of where a patient’s family originates.
Related Coverage
References
- Ebebecar SM, Salame M, MohamedHameyin, et al. HLA-DQB1*02, HLA-DRB1*03 alleles and HLA-DQB1*02-HLA-DRB1*03 haplotype confer a significant risk of celiac disease in the Mauritanian population. BMC Gastroenterology. Published July 16, 2026. doi:10.1186/s12876-026-05086-9. PubMed